Market Insights Consumer OTC Pharmaceuticals

Sleep Aids - Indonesia

Indonesia

Revenue in the Sleep Aids market amounts to €72.27m in 2024. The market is expected to grow annually by 9.51% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€1,950m in 2024).
In relation to total population figures, per person revenues of €0.26 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Sleep Aids market in Indonesia has been experiencing significant growth in recent years.

Customer preferences: Indonesian consumers are increasingly recognizing the importance of a good night's sleep and are becoming more aware of the potential health benefits of sleep aids. This has led to a growing demand for sleep aids in the country. Additionally, the increasing prevalence of sleep disorders such as insomnia and sleep apnea has also contributed to the rising demand for sleep aids among Indonesian consumers.

Trends in the market: One of the key trends in the Sleep Aids market in Indonesia is the growing popularity of natural and herbal sleep aids. Indonesian consumers are increasingly turning to natural remedies and traditional herbs to improve their sleep quality. This trend is driven by the perception that natural sleep aids are safer and have fewer side effects compared to pharmaceutical sleep aids. As a result, there has been a surge in the availability of natural sleep aids in the Indonesian market. Another trend in the Sleep Aids market in Indonesia is the increasing availability of sleep aids in various forms such as pills, sprays, and teas. This allows consumers to choose the format that best suits their preferences and needs. Additionally, the market has also witnessed the introduction of innovative sleep aids that combine multiple ingredients to target specific sleep issues, such as difficulty falling asleep or staying asleep.

Local special circumstances: Indonesia is a country with a large population and a growing middle class. This has created a favorable market for sleep aids as more people have the means to afford these products. Additionally, the hectic and stressful lifestyles of urban Indonesians have also contributed to the demand for sleep aids. The fast-paced nature of modern life often leads to sleep disturbances, and sleep aids offer a convenient solution for individuals looking to improve their sleep quality.

Underlying macroeconomic factors: The growing Sleep Aids market in Indonesia can be attributed to several underlying macroeconomic factors. Firstly, the country's economic growth has led to an increase in disposable income, allowing more consumers to afford sleep aids. Secondly, the expanding healthcare sector in Indonesia has raised awareness about sleep disorders and the importance of sleep, leading to a higher demand for sleep aids. Lastly, the increasing urbanization in the country has resulted in a rise in stress levels and sleep disturbances among the population, further driving the demand for sleep aids. In conclusion, the Sleep Aids market in Indonesia is experiencing significant growth due to the increasing awareness of the importance of sleep and the rising prevalence of sleep disorders. The market is characterized by the growing popularity of natural sleep aids and the availability of sleep aids in various forms. The large population and growing middle class in Indonesia, along with the country's economic growth, expanding healthcare sector, and urbanization, are the underlying macroeconomic factors driving the growth of the Sleep Aids market in Indonesia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.